Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal‐related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes"
DOI: 10.1111/dom.13935
Abstract: To examine the glucose‐lowering mechanisms of the glucagon‐like peptide‐1 receptor agonist lixisenatide after two subsequent meals and in combination with basal insulin. read more here.
Keywords: combination; insulin; sequential treatment; diabetes effects ... See more keywords
Effects of co‐ingesting glucose and whey protein on blood glucose, plasma insulin and glucagon concentrations, and gastric emptying, in older men with and without type 2 diabetes
Sign Up to like & getrecommendations! Published in 2023 at "Diabetes"
DOI: 10.1111/dom.14983
Abstract: To investigate whether co‐ingestion of dietary protein with, or before, carbohydrate may be a useful strategy to reduce postprandial hyperglycaemia in older men with type 2 diabetes (T2D). read more here.
Keywords: glucose whey; ingesting glucose; older men; type diabetes ... See more keywords
Effects of residential summer camp on body mass index and body composition in type 1 diabetes
Sign Up to like & getrecommendations! Published in 2018 at "Pediatric Diabetes"
DOI: 10.1111/pedi.12649
Abstract: Body mass index (BMI) and fat mass may be higher in children with diabetes compared to healthy peers. It is not certain how diabetic children respond to exercise and diet interventions. read more here.
Keywords: body mass; mass index; mass; diabetes effects ... See more keywords
Effects of luseogliflozin on the secretion of islet hormones and incretins in patients with type 2 diabetes.
Sign Up to like & getrecommendations! Published in 2022 at "Endocrine journal"
DOI: 10.1507/endocrj.ej21-0696
Abstract: The insufficient activity of insulin and the hyperactivity of glucagon are responsible for glucose intolerance in patients with type 2 diabetes. Whereas sodium-glucose cotransporter-2 (SGLT2) inhibitors improve blood glucose levels in patients with type 2… read more here.
Keywords: patients type; effects luseogliflozin; secretion; luseogliflozin secretion ... See more keywords